Naproxen-probenecid interaction. 1978

R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
March 1981, Clinical pharmacology and therapeutics,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
November 1980, Journal of pharmaceutical sciences,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
August 1986, British journal of rheumatology,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
March 1993, Journal of pharmaceutical sciences,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
January 1984, Biopharmaceutics & drug disposition,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
August 1974, British journal of clinical pharmacology,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
June 1986, Journal of clinical psychopharmacology,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
June 1986, Lancet (London, England),
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
August 1975, Toxicology and applied pharmacology,
R Runkel, and E Mroszczak, and M Chaplin, and H Sevelius, and E Segre
May 1980, Journal of pharmaceutical sciences,
Copied contents to your clipboard!